ROBERT L VAN NOSTRAND
CIK 1225198 · last filed 2026-01-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$649.1K
Companies
6
Total Filings
136
Lifetime Open-Market Net
-$5.28M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SLS | Director | 82,900 | $7.83 | $649.1K | $14.8K | 11 | 2026-01-09 |
| Intra-Cellular Therapies, Inc. (ITCI) Delisted | Director | 0 | $131.87 | $0 | -$5.32M | 59 | 2025-04-02 |
| YIELD10 BIOSCIENCE, INC. (YTEN) Delisted | Director | 48,635 | $0.35 | $17.0K | $0 | 34 | 2024-04-01 |
| ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | Director | 0 | — | — | $0 | 13 | 2020-01-29 |
| YIELD10 BIOSCIENCE, INC. (MBLX) Delisted | Director | 31,250 | — | — | $21.4K | 11 | 2015-09-14 |
| ACHILLION PHARMACEUTICALS INC (TPTX) Delisted | Director | — | $76.01 | — | $0 | 4 | 2008-12-17 |
Recent Filings · Page 3 of 14
136 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-04-19 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Mixed | — | -$499.5K | EDGAR |
| 2023-04-04 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Grant (A) | +95 | $5.1K | EDGAR |
| 2023-04-04 | YIELD10 BIOSCIENCE, INC. (YTEN) Delisted | Grant (A) | +1,642 | $0 | EDGAR |
| 2023-02-03 | SLS | Grant (A) | +2,500 | $0 | EDGAR |
| 2023-01-04 | YIELD10 BIOSCIENCE, INC. (YTEN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-01-03 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Grant (A) | +97 | $5.1K | EDGAR |
| 2022-10-05 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Grant (A) | +110 | $5.1K | EDGAR |
| 2022-10-03 | YIELD10 BIOSCIENCE, INC. (YTEN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-08-12 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Mixed | — | -$1.33M | EDGAR |
| 2022-07-05 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Grant (A) | +108 | $6.2K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.